In this setting, bitopertin produced a significant reduction in the accumulation of the toxic metabolite protoporphyrin IX (PPIX), along with improvements in selected pain- and phototoxicity-related endpoints, although some measures did not reach statistical significance relative to placebo ( Yeung et al., 2025 ).
← all excerpts
Glycine transport inhibitors for the treatment of chronic pain conditions: the time is ripe for clinical evaluation!
1
—
—